Search For "clinical"
SC reserves order on disclosure of COVID-19 vaccine clinical trial data, p
Updated : 4 years ago IST
New Delhi [India], March 23 (ANI): The Supreme Court on Monday reserved its order on a PIL seeking public disclosure of COVID-19 vaccine clinical trial data and post-vaccination data which claimed that it is mandatory and required that the government must publish the data "as per internat
Read More
Seraseal, world's most advanced, next generation Hemostatic Technology, No
Updated : 4 years ago IST
Chandigarh [India], March 22 (ANI/PNN): SeraSeal is an innovative primary haemostatic agent designed to stop bleeding on contact and within seconds for arterial haemorrhages. It comprises agar and bovine factor proteins II a VII a and IX a and X a and acts as a catalyst in the clot formation
Read More
Dr. Bharat Agravat creates Life-Saving Invention OSMF Mouth Opening Kit to
Updated : 4 years ago IST
Ahmedabad (Gujarat) [India], March 21 (ANI/BusinessWire India): What People Didn't Know About the Link Between Oral Cancer and Oral Submucous Fibrosis.
Read More
No fertility benefits from weight loss, finds study
Updated : 4 years ago IST
Washington [US], March 19 (ANI): There are no fertility benefits from weight loss, a recent clinical study has confirmed.
Read More
AQuity accelerates growth and scale with the acquisition of Acusis
Updated : 4 years ago IST
New Delhi [India], March 16 (ANI/SRV): AQuity Solutions, a leading provider of virtual solutions for real-time clinical documentation, medical coding, and mid-revenue cycle offerings announced the acquisition of Pittsburgh, PA and India based Acusis.
Read More
Cellular therapy improves signs, symptoms of Duchenne muscular dystrophy:
Updated : 4 years ago IST
Washington [US], March 14 (ANI): A recent clinical trial led by the University of California has shown that cellular therapy is safe and effective in stopping the deterioration of upper limb and heart functions in patients with late-stage Duchenne muscular dystrophy.
Read More
Lower, more frequent doses of Nanomedicines can help in enhancing cancer t
Updated : 4 years ago IST
Washington [US], March 13 (ANI): Even though nanoparticles, which are tiny structures, can be used to carry substances to certain parts of the body, hence offering hope for improving cancer therapeutics, the survival benefits of clinically approved nanomedicines are often modest in compariso
Read More
Bharat Biotech's intranasal booster vaccine can be a game-changer if it pr
Updated : 4 years ago IST
New Delhi [India], March 11 (ANI): Bharat Biotech's intranasal booster vaccine can be a game-changer if it provides mucosal immunity against COVID-19, said Dr Sanjay Rai, Professor for Community Medicine at AIIMS as the clinical trials for the vaccine commenced on Friday.
Read More
Research finds COVID-19 vaccination benefits cancer patients
Updated : 4 years ago IST
Washington [US], March 11 (ANI): Cancer patients with compromised immune systems due to their disease or therapy remain at high risk for COVID-19 infection. While clinical trials showed vaccination could prevent or lessen the risk of severe illness in healthy individuals, it has been uncl
Read More
Everlife acquires Research Instruments Group and other laboratory supplier
Updated : 4 years ago IST
Singapore [Singapore], March 10 (ANI/PR Newswire): Everlife Holdings Pte Ltd ("Everlife"), a leading market access and distribution company in India and South East Asia, has announced the completion of its acquisition of Research Instruments Group ("RI"), a leading provider of scientific and
Read More
AIIMS Delhi to start clinical trial of intranasal COVID-19 vaccine from Fr
Updated : 4 years ago IST
New Delhi [India], March 9 (ANI): All India Institute of Medical Sciences (AIIMS) Delhi will start the clinical trials of Bharat Biotech's intranasal booster dose against COVID-19 from Friday, said sources.
Read More
Pfizer starts Phase 2/3 clinical study to evaluate safety, efficacy of COV
Updated : 4 years ago IST
Washington [US], March 9 (ANI): Pharmaceutical company Pfizer on Tuesday (local time) stated that it has started the Phase 2/3 clinical study to evaluate the safety and efficacy of its COVID-19 oral treatment in the pediatric population at risk of progression to severe disease.
Read More